Recall Record

Cambridge, MA, United States

Foundation Medicine, Inc. recalls

9 recalls recorded since 2018, most recently on 10 June 2026. 7 are listed as ongoing. Status and classification are as published by the FDA.

Recalls9
Ongoing (FDA)7
Terminated or completed2
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
10 June 2026
Reason
Software issue that can cause an increase in spontaneous software closures.
Distribution
US Nationwide distribution in the states of MA & NC.
Initiated
Voluntary: Firm initiated
Recall number
Z-2951-2026

Ongoing Class II Medical devices

Recall started
24 March 2026
Reason
Potential for spontaneous closures of Hamilton HxRunControl software during execution of Autolys protocols after deployment of the PCT software for AutoLys Hamilton STAR.
Distribution
US distribution to North Carolina and Massachusetts.
Initiated
Voluntary: Firm initiated
Recall number
Z-1937-2026

Ongoing Class II Medical devices

Recall started
20 March 2026
Reason
Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants
Distribution
US Nationwide distribution in the states of Massachusetts and North Carolina.
Initiated
Voluntary: Firm initiated
Recall number
Z-1927-2026

Ongoing Class II Medical devices

Recall started
9 April 2025
Reason
Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.
Distribution
Worldwide - US Nationwide distribution in the states of GA, NY and the country of Russia.
Initiated
Voluntary: Firm initiated
Recall number
Z-1747-2025

Ongoing Class II Medical devices

Recall started
18 June 2024
Reason
Two (2) reports were sent to customers with an incorrect negative claim on the claims page; the device variant information was displayed correctly in the tumor profiling section of both FDA-approved test reports.
Distribution
US Nationwide distribution in the state of MI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1890-2025

Ongoing Class II Medical devices

Recall started
15 February 2023
Reason
An incorrect negative claim was identified on the claims page; the device variant information was displayed correctly in the tumor profiling section of the FDA-approved test report.
Distribution
US Nationwide distribution in the state of WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1891-2025

Ongoing Class II Medical devices

Recall started
8 November 2022
Reason
Reports were sent to customers without the companion diagnostic (CDx) Claims Page. Claims pages were distributed via amended reports within 7 days of the issue occurrence.
Distribution
US Nationwide distribution to states of: AL, AZ, CA, FL, GA, IL, IN, KS, KY, ME, MN, MO, MS, MT, NC, NJ, NV, NY, OK, PA, PR, SD, TN, TX, UT, VA, WA, WI, WV. OUS International to countries: Japan, Singapore.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0577-2026, Z-0578-2026

Terminated Class II Medical devices

Recall started
8 August 2019
Terminated
19 July 2021
Reason
Identified potential false positive MSI-H on the test reports provided to the physicians.
Distribution
MA, NC,IN, OH, GA
Initiated
Voluntary: Firm initiated
Recall number
Z-0535-2020

Terminated Class II Medical devices

Recall started
31 October 2018
Terminated
17 April 2020
Reason
An incorrect test result for a single analyte may have been reported for up to 800 physician reports
Distribution
US nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0649-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.